In this webinar, experts Al Gresch and Patrick Trim shared a better way to optimize capital spending and avoid unnecessary expenses with a comprehensive technology assessment program.
Browsing: Industry News
The Radiological Society of North America (RSNA) is inviting proposals from researchers for funding support to help gather and submit data to the Medical Imaging and Data Resource Center (MIDRC), an open-source database of COVID-19 related images and clinical data.
FUJIFILM Medical Systems U.S.A., Inc., a provider of diagnostic imaging and medical informatics solutions, has launched the Persona RF PREMIUM in the United States.
Many medical devices are reusable and need maintenance and repair. Servicing of devices is critical to their safe and effective…
KA Imaging has entered into a distribution agreement with BeyMed for distribution of KA imaging innovative dual-energy imaging solution Reveal…
Ultrasound is the fastest growing imaging modality in U.S health care, driving sufficient ubiquity in point-of-care ultrasound (POCUS) that major medical societies are formally examining the implications of its rapid increase.
The Radiological Society of North America (RSNA) has signed a transitional “Read and Publish” agreement with Jisc, an education and research not-for-profit organization based in the United Kingdom.
Bringing the power of artificial intelligence (AI) to molecular imaging, Advanced intelligent Clear-IQ Engine (AiCE), Canon Medical Systems USA Inc.’s Deep Learning Reconstruction (DLR) technology, is now 510(k) cleared on the Cartesion Prime Digital PET/CT system and will be showcased at SNMMI 2021 for both PET and CT acquisitions.
Hyperfine Inc., creators of the world’s first portable compact magnetic resonance imaging device, has named medical device industry veteran Dave Scott as its president and chief executive officer to support the company’s commercialization and growth strategy.
The Medical Imaging & Technology Alliance (MITA) commended the U.S. Food and Drug Administration (FDA) following its decision to grant approval of aducanumab, a move that will give patients access to the first-ever disease-modifying treatment for Alzheimer’s.
